RETRACTED ARTICLE: Mesenchymal stem cells-derived exosomal microRNA-139-5p restrains tumorigenesis in bladder cancer by targeting PRC1

[1]  Yair Lotan,et al.  Bladder cancer , 2020, Nature Reviews Disease Primers.

[2]  H. Zeng,et al.  Exosomal miRNA‐1231 derived from bone marrow mesenchymal stem cells inhibits the activity of pancreatic cancer , 2019, Cancer medicine.

[3]  B. Fu,et al.  MicroRNA-194 inhibits cell invasion and migration in hepatocellular carcinoma through PRC1-mediated inhibition of Wnt/β-catenin signaling pathway. , 2019, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[4]  Zhong-yang Liu,et al.  A novel bacterial cellulose membrane immobilized with human umbilical cord mesenchymal stem cells-derived exosome prevents epidural fibrosis , 2018, International journal of nanomedicine.

[5]  M. El-Magd,et al.  Potential Effect of Exosomes Derived from Cancer Stem Cells and MSCs on Progression of DEN-Induced HCC in Rats , 2018, Stem cells international.

[6]  Dongming Liu,et al.  Microrna‐139‐5p inhibits epithelial‐mesenchymal transition and fibrosis in post‐menopausal women with interstitial cystitis by targeting LPAR4 via the PI3K/Akt signaling pathway , 2018, Journal of cellular biochemistry.

[7]  Hui Wang,et al.  Reversal of cisplatin resistance by microRNA-139-5p-independent RNF2 downregulation and MAPK inhibition in ovarian cancer. , 2018, American journal of physiology. Cell physiology.

[8]  Qian Sun,et al.  MicroRNA-139-5P inhibits human prostate cancer cell proliferation by targeting Notch1 , 2018, Oncology letters.

[9]  Jindan Yu,et al.  BMI1 regulates androgen receptor in prostate cancer independently of the polycomb repressive complex 1 , 2018, Nature Communications.

[10]  C. Jorgensen,et al.  Mesenchymal stem cells-derived exosomes are more immunosuppressive than microparticles in inflammatory arthritis , 2018, Theranostics.

[11]  Chuanjiang He,et al.  Exosome Theranostics: Biology and Translational Medicine , 2018, Theranostics.

[12]  Kai Wang,et al.  MiR‐139‐5p inhibits the tumorigenesis and progression of oral squamous carcinoma cells by targeting HOXA9 , 2017, Journal of cellular and molecular medicine.

[13]  S. Mowla,et al.  MicroRNA-100 shuttled by mesenchymal stem cell-derived exosomes suppresses in vitro angiogenesis through modulating the mTOR/HIF-1α/VEGF signaling axis in breast cancer cells , 2017, Cellular Oncology.

[14]  Xiuheng Liu,et al.  MicroRNA-139-5p inhibits bladder cancer proliferation and self-renewal by targeting the Bmi1 oncogene , 2017, Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine.

[15]  Qingqing Zhu,et al.  PRC1 contributes to tumorigenesis of lung adenocarcinoma in association with the Wnt/β-catenin signaling pathway , 2017, Molecular Cancer.

[16]  G. Yousef,et al.  Liquid biopsy: a step forward towards precision medicine in urologic malignancies , 2017, Molecular Cancer.

[17]  Yu Cao,et al.  Elevated PRC1 in gastric carcinoma exerts oncogenic function and is targeted by piperlongumine in a p53‐dependent manner , 2017, Journal of cellular and molecular medicine.

[18]  Y. Lotan,et al.  Bladder cancer , 2016, The Lancet.

[19]  N. Seki,et al.  Dual tumor‐suppressors miR‐139‐5p and miR‐139‐3p targeting matrix metalloprotease 11 in bladder cancer , 2016, Cancer science.

[20]  M. Amiji,et al.  Exosome mediated communication within the tumor microenvironment. , 2015, Journal of controlled release : official journal of the Controlled Release Society.

[21]  Xianjun Wang,et al.  MicroRNA-139-5p acts as a tumor suppressor by targeting ELTD1 and regulating cell cycle in glioblastoma multiforme. , 2015, Biochemical and biophysical research communications.

[22]  Weigang Yuan,et al.  Knockdown of Bmi1 inhibits bladder cancer cell growth both in vitro and in vivo by blocking cell cycle at G1 phase and inducing apoptosis , 2015, Journal of Huazhong University of Science and Technology. Medical sciences = Hua zhong ke ji da xue xue bao. Yi xue Ying De wen ban = Huazhong keji daxue xuebao. Yixue Yingdewen ban.

[23]  M. Knowles,et al.  Polycomb Repressor Complex 1 Member, BMI1 Contributes to Urothelial Tumorigenesis through p16-Independent Mechanisms , 2015, Translational oncology.

[24]  A. Vickers,et al.  Prognostic and Prediction Tools in Bladder Cancer: A Comprehensive Review of the Literature. , 2015, European urology.

[25]  K. Xue,et al.  MicroRNA-139-5p inhibits cell proliferation and invasion by targeting insulin-like growth factor 1 receptor in human non-small cell lung cancer. , 2015, International journal of clinical and experimental pathology.

[26]  Xin Sheng Wang,et al.  Heterogeneity research in muscle-invasive bladder cancer based on differential protein expression analysis , 2014, Medical Oncology.

[27]  Zhonghan Li,et al.  Therapeutic targeting of microRNAs: current status and future challenges , 2014, Nature Reviews Drug Discovery.

[28]  Jun Yu,et al.  microRNA-139-5p exerts tumor suppressor function by targeting NOTCH1 in colorectal cancer , 2014, Molecular Cancer.

[29]  Xiao-hou Wu,et al.  Exosome-derived microRNA-29c induces apoptosis of BIU-87 cells by down regulating BCL-2 and MCL-1. , 2014, Asian Pacific journal of cancer prevention : APJCP.

[30]  Yan Zhang,et al.  MicroRNAs as novel biological targets for detection and regulation. , 2014, Chemical Society reviews.

[31]  Hongwei Liu,et al.  Knockdown BMI1 expression inhibits proliferation and invasion in human bladder cancer T24 cells , 2013, Molecular and Cellular Biochemistry.

[32]  N. Seki,et al.  Aberrant expression of microRNAs in bladder cancer , 2013, Nature Reviews Urology.

[33]  C. Croce,et al.  MicroRNAs in Cancer. , 2009, Annual review of medicine.

[34]  P. Altevogt,et al.  Systemic presence and tumor-growth promoting effect of ovarian carcinoma released exosomes. , 2009, Cancer letters.

[35]  Jacques Ferlay,et al.  Bladder Cancer Incidence and Mortality: A Global Overview and Recent Trends. , 2017, European urology.

[36]  C. Croce,et al.  MicroRNAs in cancer. , 2014, Annual review of pathology.

[37]  H. Ozen.  Bladder cancer. , 1998, Current opinion in oncology.